Lv1
86 积分 2023-02-17 加入
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer’s disease
3天前
已关闭
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
27天前
已完结
Atrasentan in Patients with IgA Nephropathy
28天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
28天前
已完结
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
28天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
28天前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
28天前
已完结
Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020
1个月前
已完结
Withdrawal of Fenoterol and the End of the New Zealand Asthma Mortality Epidemic
1个月前
已关闭
Immunosuppressive therapy for IgA nephropathy in children
1个月前
已关闭
皖公网安备34019202002308
